Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference5 articles.
1. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity;Mintz-Hittner;N Engl J Med,2011
2. Reactivation of retinopathy of prematurity after bevacizumab injection;Hu;Arch Ophthalmol,2012
3. Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity;Tahija;Br J Ophthalmol,2014
4. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial;Early Treatment For Retinopathy of Prematurity Cooperative Group;Arch Ophthalmol,2003
5. Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up;Isaac;Eye (Lond),2016
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography;Scientific Reports;2023-11-15
2. A Network Meta-Analysis of Success Rates following Low Dosage Anti-VEGF for Retinopathy of Prematurity;Current Eye Research;2023-09-28
3. Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography;2023-04-05
4. Long-term outcomes of type 1 retinopathy of prematurity following monotherapy with bevacizumab: a Canadian experience;Canadian Journal of Ophthalmology;2022-08
5. Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF;European Journal of Ophthalmology;2022-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3